The food and grocery delivery company’s idea of providing prescription drugs in 10 minutes is facing resistance from traditional pharma players.
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
Limited time offer $125 $99 for 1 year
With the food delivery business at a near standstill, Zomato needs its quick commerce arm to best the competition—no easy task when the top three players are neck and neck and more look to join the race.
It is tough but not impossible to put a respectable end to a failed business. As creditors fight for their dues, Dunzo’s investors and management have a lot to answer for.
Acquired in desperation, the restaurant discovery and table reservation platform has largely been a forgotten enterprise inside Swiggy. That may be about to change.